AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
-5.45%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.74B
AUM Growth
-$558M
(-13%)
Cap. Flow
-$165M
Cap. Flow
% of AUM
-4.4%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
292
New
63
Increased
75
Reduced
60
Closed
70
Top Buys
| 1 |
Freshpet
FRPT
|
$59.6M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$54.6M |
| 3 |
Keurig Dr Pepper
KDP
|
$37.6M |
| 4 |
STAAR Surgical
STAA
|
$37.5M |
| 5 |
Smith & Nephew
SNN
|
$36.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.4M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$79.9M |
| 3 |
GSK
GSK
|
$77.5M |
| 4 |
AB InBev
BUD
|
$68M |
| 5 |
Humana
HUM
|
$67.7M |
Sector Composition
| 1 | Healthcare | 63.24% |
| 2 | Consumer Discretionary | 12.22% |
| 3 | Consumer Staples | 9.75% |
| 4 | Technology | 9.6% |
| 5 | Communication Services | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
O'Reilly Automotive
ORLY
$89B
| $5.94M | 0.09% |
62,235
-5,490
| -8% | -$524K |
|
102
Murphy USA
MUSA
$7.47B
| $5.83M | 0.09% |
+12,408
| New | +$5.83M |
|
103
Coupang
CPNG
$52.7B
| $5.8M | 0.09% |
264,375
-92,497
| -26% | -$2.03M |
|
104
Chipotle Mexican Grill
CMG
$55.1B
| $5.72M | 0.09% |
114,000
+14,131
| +14% | +$710K |
|
105
Pfizer
PFE
$141B
| $5.37M | 0.08% |
+211,740
| New | +$5.37M |
|
106
Best Buy
BBY
$16.1B
| $5.31M | 0.08% |
72,144
-15,533
| -18% | -$1.14M |
|
107
PDS Biotechnology
PDSB
$56.4M
| $5.26M | 0.08% |
+4,419,000
| New | +$5.26M |
|
108
Lowe's Companies
LOW
$151B
| $5.17M | 0.08% |
22,147
-33,010
| -60% | -$7.7M |
|
109
Boston Scientific
BSX
$159B
| $5.02M | 0.08% |
+49,762
| New | +$5.02M |
|
110
Sherwin-Williams
SHW
$92.9B
| $4.89M | 0.07% |
+14,018
| New | +$4.89M |
|
|
MDCX
111
Medicus Pharma Ltd. Common Stock
MDCX
$35.2M
| $4.71M | 0.07% |
+1,266,000
| New | +$4.71M |
|
112
VolitionRX
VNRX
$64.8M
| $4.68M | 0.07% |
8,206,430
-275,465
| -3% | -$157K |
|
113
Las Vegas Sands
LVS
$36.9B
| $4.67M | 0.07% |
120,822
-28,792
| -19% | -$1.11M |
|
114
Edwards Lifesciences
EW
$47.5B
| $4.57M | 0.07% |
62,995
-106,834
| -63% | -$7.74M |
|
115
Accuray
ARAY
$170M
| $4.54M | 0.07% |
2,536,000
+1,300,000
| +105% | +$2.33M |
|
116
Magnite
MGNI
$3.54B
| $4.44M | 0.07% |
+389,000
| New | +$4.44M |
|
|
VRNA
117
Verona Pharma
VRNA
$9.2B
| $4.33M | 0.06% |
+68,201
| New | +$4.33M |
|
118
Lennar Class A
LEN
$36.7B
| $4.02M | 0.06% |
+35,000
| New | +$4.02M |
|
119
Ferguson
FERG
$47.8B
| $3.85M | 0.06% |
+24,000
| New | +$3.85M |
|
120
Verrica Pharmaceuticals
VRCA
$48.2M
| $3.79M | 0.06% |
856,740
-35,360
| -4% | -$156K |
|
121
Reddit
RDDT
$44.9B
| $3.78M | 0.06% |
36,000
+17,000
| +89% | +$1.78M |
|
122
Ulta Beauty
ULTA
$23.1B
| $3.75M | 0.06% |
10,236
-13,609
| -57% | -$4.99M |
|
123
Cibus
CBUS
$67.3M
| $3.64M | 0.05% |
+1,948,000
| New | +$3.64M |
|
124
RxSight
RXST
$364M
| $3.59M | 0.05% |
+142,036
| New | +$3.59M |
|
125
Alto Neuroscience
ANRO
$99.4M
| $3.46M | 0.05% |
1,600,000
+950,000
| +146% | +$2.05M |
|